🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Lung Transplant Candidates: Effects of Aerobic vs. HIIT Training on ICF Assessments

RecruitingNAAges 18 Years - 64 YearsAllAnkara City Hospital Bilkent
NCT07065318 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Lung transplantation is a crucial surgical intervention aimed at increasing survival rates in patients with end-stage lung diseases such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, idiopathic pulmonary fibrosis, and pulmonary hypertension. One of the most important determinants of health outcomes before and after lung transplantation is exercise capacity. An increase in the 6-minute walking distance (6MWD), which serves as a measure of functional exercise capacity, is associated with lower mortality rates in both pre- and post-transplantation settings. Therefore, effective rehabilitation programs are needed to enhance the exercise capacities of lung transplant candidates. Pulmonary rehabilitation (PR) is a comprehensive program designed specifically for individuals with chronic respiratory diseases. PR aims to improve patients\' physical and psychological condi

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Being diagnosed with interstitial lung disease and being followed up at the Ankara City Hospital Chest Diseases Clinic, * Being 18 years of age or older, * Patients who are being followed up with a diagnosis of ILD according to the ATS/ERS 2022 international ILD guideline, * Being on the lung transplant waiting list according to the International Society for Heart and Lung Transplantation and are being evaluated for listing and are being followed up by the chest diseases department (25-28), * Being willing to participate in the exercise program regularly and volunteering to participate in the study, * Patients who have dyspnea levels of 2 and above according to the Modified Medical Research Council dyspnea scale and are able to ambulate, * Patients who receive long-term oxygen support will be included. Exclusion Criteria: * Patients with a history of exertional syncope, * Patients in acute exacerbation, * Patients with sarcoidosis, * Patients with serious comorbidities that may limit exercise (e.g. musculoskeletal, neurological or cardiovascular problems) will not be included. * Patients with an aortic aneurysm greater than 5.5 cm, * Patients with cardiovascular impediments to exercise during cardiological evaluations prior to pulmonary rehabilitation
💊

What it tests

  • LV-HIIT (Low-Volume High-Intensity Interval Training)
  • MICT (Moderate-Intensity Continuous Training)
  • Ergometer cycle
📍

Where

1 site
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy